or
Continue with FacebookLooking to list your PhD opportunities? Log in here.
We have 137 Cancer Biology PhD Projects, Programmes & Scholarships for Non-European Students in the UK
Cancer Biology PhD Projects, Programmes & Scholarships for Non-European Students in the UK
We have 137 Cancer Biology PhD Projects, Programmes & Scholarships for Non-European Students in the UK
Understanding the role of cancer-associated SF3B1 mutation in microRNA biogenesis.
In this PhD project, the student will investigate how cancer-associated mutation in the splicing factor SF3B1 affects microRNA biogenesis. Read more
Investigation of the biological behaviour of feline injection site sarcomas to identify potential biomarkers and develop new therapies
Vaccination is a commonly performed procedure in cats, which is highly successful at protecting the animals against a variety of diseases. Read more
EASTBIO: Location,location, location: DNA damage sensors which launch protective responses to DNA damage
DNA damage happens at very high frequency in the cells in our bodies – meaning that the instructions for the proper functioning of cells could be altered unless the mistakes are spotted and corrected. Read more
EASTBIO: Hijacking new E3 ubiquitin ligases for targeted degradation of trans-membrane receptors.
Targeted protein degradation (TPD) is emerging as an exciting modality for research and therapeutic applications. Molecular glue degraders and proteolysis-targeting chimeras (PROTACs) hijack the cellular ubiquitin-proteasome (UPS) pathways to target the destruction of mainly intracellular target proteins. Read more
Investigation of loss of Y chromosome and its functional role in driving disease progression and immune evasion in cutaneous and oral squamous cell carcinoma
This CRUK Barts Cancer Bioinformatics Core funded project will commence in September 2025 and has funding for 4 years. This project would suit candidates with a background in genomics and bioinformatics and an interest in cancer genomics, spatial biology, digital pathology and sex disparities in cancer. Read more
EASTBIO: Studying kinetochore dynamics on a nanometre scale to reveal mechanisms ensuring correct chromosome segregation in mitosis
When eukaryotic cells divide, the whole set of chromosomes must be inherited by daughter cells. To ensure this, cells must correctly segregate duplicated chromosomes to opposite spindle poles during mitosis before the cell division. Read more
EASTBIO-Investigating phosphoinositide acyl chain composition as a novel regulator of T cell signalling during ageing
Research Group:
Centre for Inflammation Research
Healthy life expectancy is declining in the UK, particularly in deprived areas where the number of years spent in good health can vary by up to 26 years. Read more
Last chance to apply
MRC DiMeN Doctoral Training Partnership: Regulation of transcription replication conflicts in cancer: mechanism and functional implications in acute myeloid leukemia
This project focuses on the emerging field of transcription-replication conflicts (TRCs) in cancer. In cancer cells, oncogenic transcription is essential for unrestricted cancer cell proliferation, yet it also causes genomic instability during DNA synthesis. Read more
Last chance to apply
MRC DiMeN Doctoral Training Partnership: Exploring the anti-fibrotic activity and underlying molecular mechanisms of targeted compounds in patient derived models of Dupuytren’ disease and cancer
Fibrosis is characterised by an excessive accumulation of collagen within tissues, which impedes tissue function. Organ fibroses have limited treatment options, create a clinical burden and are life-limiting diseases1. Read more
Last chance to apply
MRC DiMeN Doctoral Training Partnership: Characterization of immunological responses in patients with liver cancer to predict immunotherapy efficacy and immune-related adverse events
Liver cancer, a devastating and incurable cancer has poor patient outcomes largely due to late-stage diagnosis, limited treatment options, and lack of biomarkers for early detection and monitoring of disease progression and treatment response. Read more
Last chance to apply
MRC DiMeN Doctoral Training Partnership: Bioengineering a protein nanocage as a novel drug and antigen vaccine delivery platform for cancer therapeutics
Are you passionate about making a difference in cancer treatment? Join our exciting PhD project developing cutting-edge nanotechnology to outsmart cancer!. Read more
Last chance to apply
MRC DiMeN Doctoral Training Partnership: A novel theragnostic approach for treating brain tumours
This multidisciplinary project will use cutting edge imaging technologies along with novel chemistry and a cell-based therapy to treat glioblastomas, the deadliest form of brain cancer in adults. These tumours have a dismal survival of less than 14 months. Read more
Unveiling intercellular dynamics in cancer progression using deep learning on single-cell and spatial transcriptomics data
The project. Colorectal carcinoma (CRC) is the second deadliest cancer worldwide, with a 5-year overall survival rate below 10%. CRC is classified into four consensus molecular subtypes (CMS1–4). Read more
Modelling the Human Cancer Genome
The project. Following on from work on integrative methods for machine learning, and with collaborators such as Tom Gaunt at the University of Bristol, we have been developing integrative methods for identifying disease-driver variants in the human cancer genome (see [1] for a review, also [2]). Read more